#1 Clinical Trials Search in Europe

CITRIC ACID ANHYDROUS

Anhydrous citric acid is a versatile compound used in various medical applications, particularly in clinical trials focusing on bowel preparation for colonoscopy and treatment of urinary stones. This article explores how anhydrous citric acid, often combined with other compounds like sodium picosulfate and magnesium oxide, functions in these medical contexts. We’ll examine recent clinical trials that have investigated its effectiveness, safety profile, and patient tolerability when used for colon cleansing before colonoscopy procedures and as a component in litholytic therapy for urinary stones. Understanding these applications provides valuable insights into the therapeutic potential of anhydrous citric acid in modern medical practice.

Table of Contents

What is Anhydrous Citric Acid?

Anhydrous citric acid is a powdered form of citric acid that contains no water molecules. “Anhydrous” means “without water.” This chemical compound is used in various medical applications due to its properties and ability to be combined with other substances to create effective treatments.[1]

Medical Uses

Based on clinical research, anhydrous citric acid is primarily used in two important medical applications:

  • As a component in bowel preparation solutions before colonoscopy procedures
  • As part of litholytic therapy (stone-dissolving treatment) for urate kidney stones

In both applications, anhydrous citric acid works alongside other ingredients to provide therapeutic benefits.[1][2]

Bowel Preparation for Colonoscopy

One of the primary uses of anhydrous citric acid is in bowel preparation solutions for patients undergoing colonoscopy. These preparations are essential for clearing the colon to allow proper visualization during the procedure.[1]

Anhydrous citric acid is commonly combined with other ingredients such as:

  • Sodium picosulfate – a stimulant laxative that increases bowel movement
  • Magnesium oxide – draws water into the intestines to help clear the bowel

This combination works in several ways to clean the bowel effectively:

  • The citric acid component helps create an acidic environment that activates the laxative effects
  • The combined ingredients stimulate bowel movements and soften stool for easier elimination
  • The solution helps flush out intestinal contents prior to examination

These preparations are available in different forms, including:

  • Ready-to-drink oral solutions that require no further preparation
  • Powder formulations that need to be reconstituted with water before use

Common brand names containing these ingredients include PREPOPIK® and PicoPrep®, though specific formulations may vary.[1][3]

Treatment of Urate Nephrolithiasis

Another important medical application of anhydrous citric acid is in the treatment of urate nephrolithiasis, a condition characterized by urate kidney stones. In this context, anhydrous citric acid is used as part of citrate mixtures for litholytic therapy (a treatment aimed at dissolving stones).[2]

For treating kidney stones, anhydrous citric acid is often combined with:

  • Potassium bicarbonate
  • Sodium citrate

This citrate mixture works by:

  • Raising urine pH to make it more alkaline
  • Creating conditions that help dissolve urate stones
  • Preventing new stone formation by maintaining appropriate urinary pH levels

In clinical studies, the dosage is individually adjusted for each patient, with a target urinary pH of approximately 7.2 being ideal for effective stone dissolution.[2]

Common Formulations and Combinations

Anhydrous citric acid is rarely used alone in medical applications. Instead, it’s typically formulated in specific combinations depending on the intended use:

For bowel preparation:

  • Sodium picosulfate (10 mg) + Magnesium oxide (3.5 g) + Anhydrous citric acid (10.97 g)
  • These may be prepared as ready-to-drink solutions (typically 160 mL bottles) or as powder sachets requiring reconstitution with water

For litholytic therapy (kidney stone treatment):

  • Anhydrous citric acid (1197.0 mg) + Potassium bicarbonate (967.5 mg) + Sodium citrate anhydrous (835.5 mg)
  • This combination is known under brand names such as “Blemaren” in some countries

The specific ratios and dosages of these ingredients are carefully calibrated to achieve the desired therapeutic effects while minimizing potential side effects.[1][2][3]

Effectiveness and Safety

Clinical studies have investigated the effectiveness and safety of anhydrous citric acid in its various applications:

For bowel preparation:

Research has focused on comparing different formulations containing anhydrous citric acid to determine which provides the best bowel cleansing with minimal patient discomfort. Studies have assessed factors such as:

  • Efficacy of colon cleansing (using standardized scales like the Modified Aronchick Scale and Boston Bowel Preparation Scale)
  • Patient tolerability and satisfaction
  • Side effects and adverse events

Research indicates that preparations containing anhydrous citric acid generally provide effective bowel cleansing when used according to instructions.[1][3]

For urate nephrolithiasis:

Studies on citrate mixtures containing anhydrous citric acid have evaluated:

  • Changes in stone size, volume, and density over time
  • Effects on kidney function (measured through glomerular filtration rate)
  • Stone composition analysis

Research suggests that these citrate mixtures can be effective in dissolving urate stones when the proper urinary pH is maintained.[2]

Potential Side Effects

While generally considered safe when used as directed, preparations containing anhydrous citric acid may cause side effects, which vary depending on the specific formulation and use:

Bowel preparation formulations may cause:

  • Gastrointestinal discomfort (nausea, vomiting, abdominal pain, bloating)
  • Bad taste in mouth
  • Sleep disturbances due to frequent bathroom trips
  • Headache
  • Dehydration or electrolyte imbalances in some cases

Citrate mixtures for kidney stones may cause:

  • Gastrointestinal disturbances
  • Changes in electrolyte balance
  • Potential interactions with other medications

Clinical trials typically monitor these side effects carefully to ensure patient safety and comfort.[1][2][3]

Patient Considerations

When using products containing anhydrous citric acid, patients should be aware of several important considerations:

For bowel preparation:

  • Follow instructions precisely regarding timing and amount of solution to consume
  • Stay hydrated with clear liquids during the preparation process
  • Be prepared for frequent bowel movements
  • Complete the entire prescribed regimen for optimal results
  • Inform your doctor about any medications you’re taking, as some may interact with bowel preparation solutions

For kidney stone treatment:

  • Regular monitoring of urine pH is essential to ensure the treatment is effective
  • Maintain consistent dosing as prescribed by your healthcare provider
  • Follow-up imaging studies may be necessary to track stone dissolution
  • Be aware that treatment may need to continue for extended periods depending on stone size and composition

In all cases, patients should report unusual or severe side effects to their healthcare provider promptly.[1][2][3]

Application Formulation Clinical Trial Key Findings
Bowel Preparation for Colonoscopy Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid – Available as ready-to-drink solution or powder for reconstitution NCT03017235: Compared liquid solution vs. powder formulation (PREPOPIK®) Evaluated efficacy using Modified Aronchick Scale and Boston Bowel Preparation Scale; assessed patient tolerability and satisfaction using Mayo Clinic Bowel Prep Tolerability Questionnaire
Pre-Surgical Bowel Cleansing Sodium picosulfate, light magnesium oxide, anhydrous citric acid (10 mg/3.5 g/10.97 g) NCT04161599: Mechanical bowel preparation combined with oral antibiotics vs. oral antibiotics alone Study evaluating impact on surgical site infections following colonic surgery; comparing bowel preparation with antibiotics versus antibiotics alone
Litholytic Therapy for Kidney Stones Citrate mixture containing anhydrous citric acid (1197.0 mg), potassium bicarbonate (967.5 mg), and sodium citrate anhydrous (835.5 mg) NCT07162974: Treatment for coral urate nephrolithiasis Individualized dosing to achieve target urinary pH of 7.2; assessed changes in stone size, volume, and density using CT imaging
Administration Methods Powder: Requires reconstitution with water before use
Liquid: Ready-to-drink solution requiring no preparation		 Across multiple trials Patient preference factors include taste, convenience, and ease of administration
Safety Considerations All formulations Monitored across all trials Common side effects include gastrointestinal discomfort, nausea, vomiting, headache, and sleep disturbances due to frequent bathroom visits

FAQ

  • What is anhydrous citric acid and how is it used in medical treatments? Anhydrous citric acid is a crystalline form of citric acid without water molecules. In medical treatments, it's commonly used as part of combination preparations for bowel cleansing before colonoscopy procedures and in litholytic therapy for dissolving urate kidney stones. It's typically combined with other substances like sodium picosulfate and magnesium oxide for bowel preparation, or with potassium bicarbonate and sodium citrate for treating urinary stones.
  • How does anhydrous citric acid help in bowel preparation for colonoscopy? Anhydrous citric acid, when combined with sodium picosulfate and magnesium oxide, creates an effective bowel cleansing solution. The citric acid component helps create an osmotic effect that draws water into the bowel, while also enhancing the laxative effect of sodium picosulfate. This combination helps clear the colon of solid waste and debris, allowing for better visualization during colonoscopy procedures. These preparations are available in different forms, including powder that needs reconstitution with water or as ready-to-drink solutions.
  • Can anhydrous citric acid be used to treat kidney stones? Yes, anhydrous citric acid is used in the treatment of certain types of kidney stones, particularly urate stones. In litholytic therapy, it's typically combined with other citrate compounds like potassium bicarbonate and sodium citrate. These citrate mixtures work by increasing urinary pH (making it more alkaline), which helps dissolve urate stones. The treatment is individualized for each patient to achieve a target urinary pH of around 7.2, which creates favorable conditions for stone dissolution.
  • What are the differences between powder and liquid forms of bowel preparation containing anhydrous citric acid? The main difference is in preparation and convenience. The powder form (like PREPOPIK®) requires patients to mix the contents of a sachet with water before consumption, stirring for 2-3 minutes to properly dissolve. The liquid form comes as ready-to-drink bottles that don't require additional preparation. Clinical trials have compared these formulations to assess differences in efficacy, tolerability, and patient satisfaction. For many patients, the ready-to-drink solution may be more convenient, while the powder form might allow for some flexibility in taste adjustment.
  • What side effects might occur when using medications containing anhydrous citric acid? Side effects of bowel preparation products containing anhydrous citric acid may include nausea, vomiting, abdominal discomfort or cramping, bloating, and headache. Some patients also report experiencing a bad taste in the mouth, gastric fullness, or sleep disturbances due to frequent bathroom trips. When used in citrate mixtures for kidney stone treatment, possible side effects might include gastrointestinal discomfort and changes in electrolyte balance. The dosage is usually carefully controlled to minimize these effects while maintaining therapeutic benefit.

Ongoing Clinical Trials on CITRIC ACID ANHYDROUS

  • Study on Immune Responses to Influenza Vaccines in Health Care Workers Using Polysorbate 80, Sodium Citrate, and Citric Acid Anhydrous

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Anhydrous Citric Acid: A form of citric acid that contains no water molecules in its structure. It's used in medical preparations for bowel cleansing and kidney stone treatment.
  • Bowel Preparation: The process of cleansing the intestines before a medical procedure such as colonoscopy, to ensure clear visualization of the intestinal lining.
  • Colonoscopy: An examination procedure where a flexible tube with a camera is inserted through the rectum to examine the colon for abnormalities such as polyps or inflammation.
  • Coralloid Nephrolithiasis: A type of kidney stone that has a coral-like branching structure, filling part of the kidney's collecting system. These stones can be particularly challenging to treat.
  • Litholytic Therapy: Medical treatment aimed at dissolving kidney stones through the use of medications rather than surgical intervention.
  • Modified Aronchick Scale: A 4-point scale used by doctors to grade colon cleansing quality during colonoscopy, ranging from 'Excellent' to 'Inadequate'.
  • Boston Bowel Preparation Scale (BBPS): A scoring system used to assess the cleanliness of different segments of the colon during colonoscopy, with scores ranging from 0 (unprepared) to 3 (perfectly clean).
  • Urate Stones: A type of kidney stone composed of uric acid. These stones form in acidic urine and can be dissolved by making the urine more alkaline.
  • Sodium Picosulfate: A stimulant laxative often combined with magnesium oxide and anhydrous citric acid in bowel preparation medications.
  • Glomerular Filtration Rate (GFR): A test that measures how well the kidneys are filtering blood, used to assess kidney function in patients with kidney stones.
  • PREPOPIK®: A commercial bowel preparation product containing sodium picosulfate, magnesium oxide, and anhydrous citric acid in powder form that must be mixed with water before use.
  • Parenteral: Administering medications through routes other than the digestive tract, such as by injection.
  • Surgical Site Infections (SSI): Infections that occur at the site of surgery within 30 days of an operation, which may be superficial, deep, or affect body cavities.
  • Anastomotic Leak: A serious complication where the surgical connection between two body structures (like sections of intestine) fails, allowing contents to leak.
  • Outcomes Assessor: A person who evaluates the results of a clinical trial but is kept unaware of which treatment each participant received to prevent bias.

References

  1. https://clinicaltrials.gov/study/NCT03017235
  2. https://clinicaltrials.gov/study/NCT07162974
  3. https://clinicaltrials.gov/study/NCT04161599